azelastine has been researched along with ciclesonide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wolthers, OD | 1 |
| Braido, F; Canonica, GW; Ferrando, M; Sclifò, F | 1 |
| Brixner, D; Carroll, CA; Lipworth, BJ; Meltzer, EO; Morland, K; Munzel, U | 1 |
2 review(s) available for azelastine and ciclesonide
| Article | Year |
|---|---|
New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
Topics: Administration, Intranasal; Adolescent; Adrenal Cortex Hormones; Adult; Androstadienes; Animals; Drug Combinations; Evidence-Based Medicine; Fluticasone; Histamine Antagonists; Humans; Mometasone Furoate; Patents as Topic; Phthalazines; Pregnadienediols; Pregnenediones; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome | 2013 |
New therapies for allergic rhinitis.
Topics: Administration, Intranasal; Androstadienes; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Benzimidazoles; Butyrophenones; Cyproheptadine; Fluticasone; Histamine H1 Antagonists; Humans; Omalizumab; Phthalazines; Piperidines; Pregnenediones; Rhinitis, Allergic; Rhinitis, Allergic, Perennial | 2014 |
1 other study(ies) available for azelastine and ciclesonide
| Article | Year |
|---|---|
IMPLICATION OF ALTERNATIVE MINIMAL CLINICALLY IMPORTANT DIFFERENCE THRESHOLD ESTIMATION METHODS ON TECHNOLOGY ASSESSMENT.
Topics: Androstadienes; Anti-Allergic Agents; Humans; Minimal Clinically Important Difference; Phthalazines; Pregnenediones; Rhinitis, Allergic, Seasonal; Technology Assessment, Biomedical | 2016 |